Hoth Therapeutics Inc. (HOTH)
0.83
-0.03 (-3.34%)
At close: Apr 25, 2025, 10:25 AM
-3.34% (1D)
| Bid | n/a |
| Market Cap | 10.94M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -8.19M |
| EPS (ttm) | -1.28 |
| PE Ratio (ttm) | -0.65 |
| Forward PE | -1.81 |
| Analyst | Buy |
| Ask | n/a |
| Volume | 11,828 |
| Avg. Volume (20D) | 707,208 |
| Open | 0.87 |
| Previous Close | 0.86 |
| Day's Range | 0.83 - 0.87 |
| 52-Week Range | 0.58 - 3.80 |
| Beta | 0.64 |
About HOTH
Hoth Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-ALZ for the treatment ...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 15, 2019
Employees 2
Stock Exchange NASDAQ
Ticker Symbol HOTH
Website https://www.hoththerapeutics.com
Analyst Forecast
According to 4 analyst ratings, the average rating for HOTH stock is "Buy." The 12-month stock price forecast is $4.5, which is an increase of 441.71% from the latest price.
Stock Forecasts3 months ago
+178.18%
Hoth Therapeutics shares are trading higher after ...
Unlock content with
Pro Subscription
5 months ago
+1.05%
Hoth Therapeutics shares are trading higher after the company announced its board has approved the purchase of up to $1 million in Bitcoin.
